BARUERI, Brasil, Feb. 21, 2017 /PRNewswire/ -- Advanced Digital Health Medicina Preventiva S.A. ("Company", "ADH", "Advanced-DH", Ticker: ADHM3), in accordance with the CVM Rule No. 358/02, hereby announces to its shareholders and to the market that its Level I American Depositary Receipt (ADR) Program ("ADR Program") has been approved by CVM (Comissao de Valores Mobiliarios) and declared effective by the SEC (Securities and Exchange Commission).
The ADR Program will be available starting on February 21st, 2017, with the following characteristics:
- Depositary Institution: The Bank of New York Mellon
- Custodian Bank: Itau Unibanco S.A.
- Security Type: Common shares issued by the Company, with no par value
- Ratio: 1 (one) ADR will represent 1 (one) American Depositary Share which will correspond to 3 (three) common shares issued by the Company
- Trading: Over the counter (OTC) market in New York, USA
- Simbolo: ADHMY
- CUSIP: 00790N103
Shareholders who intend to receive ADRs must instruct Itau Unibanco and deposit, through a securities broker, their shares issued by the Company at Itau Unibanco S.A., user 2750-2, client 1-1, portfolio 2101-6, in compliance with the deposit agreement, applicable laws and regulations.
The ADR Program is in line with the Company's strategy to be a global enterprise and aims at increasing the Company's visibility in the capital markets, promoting the stock liquidity, increasing the shareholder base and facilitating the access of the share to foreign investors.
The Level I ADR Program does not imply in any capital increase, new share issuance or a public offer for the existing shares.
Natasha Namie Nakagawa
Investor Relations Officer
(5511) 3090-6748 / (5511) 3090-6749
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/adh-adrs-eligible-for-trading-in-the-us-300411050.html